Medtronic Plc reported quarterly profit ahead of estimates on strong demand for its surgical instruments and forecast better-than-expected 2020 earnings on Thursday, sending shares of the medical device maker up nearly 3%.
* N.America revenue falls 6 pct
(Adds analyst comments, updates shares)
The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc's topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.
Walgreens Boots Alliance Inc shares fell 13 percent on Tuesday after the company cut its 2019 earnings forecast and reported a disappointing quarterly profit in the face of stubbornly low generic drug prices in a crowded market.
The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.
March 20 The U.S. Food and Drug Administration
approved Jazz Pharmaceuticals Plc's treatment for
patients with a form of sleep disorder, the company said on
Humana Inc's full-year profit forecast came in shy of analysts' estimates on Wednesday as its Medicare Prescription drug plans remained under pressure and said it expects 2019 margins in the fast-growing business to fall short of its own targets.
Jan 16 An advisory panel to the U.S. Food and
Drug Administration said on Wednesday that benefits of Amgen
Inc's osteoporosis treatment for postmenopausal women
at high risk for fracture outweighed its risks and
overwhelmingly voted for the drug's approval.
Medical device maker Medtronic Plc on Tuesday beat analysts' profit estimates for the second quarter and boosted its annual revenue growth outlook, driven by robust sales at its cardiac and surgical product units, sending its shares up 3 percent.